Imperative Care today announced study data evaluating aspiration with its Zoom system in stroke patients with M2 occlusions. Campbell, California–based Imperative Care designed Zoom for fast and effective clot removal from access through reperfusion. It treats patients with acute ischemic stroke, enabling smooth tracking through challenging vasculature. Clinical data came from a sub-analysis of patients […]
Vascular
Medtronic enrolls first patient in study for Onyx liquid embolic system
Medtronic today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES). PELE (Peripheral Onyx Liquid Embolic) evaluates the safety of Onyx LES for the embolization of arterial hemorrhage in the peripheral vasculature. Dr. Christopher Stark performed the first procedure at Albany Medical Center. Onyx LES, an ethylene vinyl […]
Medtronic to distribute Future Medical’s peripheral guidewires
Medtronic today announced an exclusive U.S. distribution agreement for Future Medical Design peripheral guidewires. Japan-based Future offers specialty and workhorse guidewires. The agreement includes the first 400 cm, 0.018″ peripheral guidewire available in the U.S., according to a news release. Medtronic says it expands its portfolio for transradial access for the treatment of peripheral arterial […]
AtriCure completes enrollment in stroke prevention trial
AtriCure today announced the completion of enrollment in a study evaluating its AtriClip system for preventing stroke. Investigators initiated the left atrial appendage exclusion for prophylactic stroke reduction (LeAAPS) clinical trial in January 2023. The study enrolled 6,500 patients across 137 centers around the globe. LeAAPS, an FDA investigational device exemption (IDE) trial, evaluates the […]
Imperative Care, Proximie partner to develop surgical robot to treat stroke
Proximie and Imperative Care today announced a partnership aimed at driving the development of a surgical robot to treat ischemic stroke. Imperative Care currently develops connected innovations to elevate care for people affected by vascular diseases. Those include catheter-based systems for strokes and pulmonary embolisms. Proximie offers a cloud-based solution that enables physicians to share […]
Real-world data backs Route 92 reperfusion system
Route 92 Medical today announced results from a real-world study evaluating reperfusion outcomes with its HiPoint system. San Mateo, California-based Route 92’s HiPoint system includes the HiPoint 88 system powered by Tenzing 8, featuring the Monopoint approach. The company says it became the first neurovascular intervention company to win clearance for direct aspiration of a […]
Medtronic, Recor praise new CMS coverage for renal denervation
Medtronic and Recor Medical both issued statements supporting new Medicare coverage for their respective renal denervation therapies. Both companies offer renal denervation (RDN) technologies for treating hypertension. Recor Medical received a landmark FDA nod for its Paradise ultrasound RDN (uRDN) system in November 2023. Medtronic, the second company with such approval, picked up its nod for the […]
Johnson & Johnson MedTech adds new CMO for its Electrophysiology business
Johnson & Johnson MedTech announced that it has a new chief medical & scientific officer for its Electrophysiology unit. Michael Bodner, group chair for Electrophysiology & Neurovascular, posted on LinkedIn that the company appointed Dr. Gregory Michaud to the role. Michaud, a globally recognized electrophysiologist, brings significant experience in the diagnosis and treatment of AFib […]
InspireMD launches carotid stent in U.S. after FDA approval
InspireMD (Nasdaq:NSPR) announced today that it launched its CGuard Prime carotid stent in the U.S. after receiving FDA premarket approval (PMA) last month. The CGuard embolic prevention stent (EPS) system — designed to prevent stroke — received CE mark last month as well. It utilizes the company’s MicroNet technology for strong acute results and durable, stroke-free, […]
Teleflex completes acquisition of Biotronik’s Vascular Intervention business
Teleflex announced today that it completed its previously announced acquisition of the Biotronik Vascular Intervention (VI) business. As part of strategy shifts by both companies, Teleflex in February agreed to acquire substantially all of the Biotronik VI unit. The acquisition adds a broad portfolio of therapeutic products to the Wayne, Pennsylvania-based company’s interventional access products. […]
STENTiT enrolls first patient in trial of regenerative stent system
STENTiT has implanted its Resorbable Fibrillated Scaffold in the first patient enrolled in the VITAL-IT 1 study evaluating the device for chronic limb-threatening ischemia (CLTI) below the knee. The prospective, non-randomized feasibility study will enroll up to 10 patients at the Medical University of Graz in Austria and follow them for 24 months. Investigators used […]
